Trials / Completed
CompletedNCT04907487
Évaluation de l'Impact du Compressed Sensing Sur le Signal QSM
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 82 (actual)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients who have agreed to participate in the study will complete the MRI protocol as part of routine care, to which a maximum of four additional 25-minute sequences will be added. MRI of routine care includes at least the following sequences: * 3D T1 TFE (2 minutes) * T2 TSE (2 minutes) * 3D FLAIR (3 minutes) The sequences added by the research lasting 25 minutes are: * SWI QSM 1.0iso 8 echoes (10 minutes) * SWI QSM 1.0iso 8 echoes CS 6 (7 minutes) * SWI QSM 1.0iso 8 echoes CS 9 (5 minutes) * SWI QSM 1.0iso 8 echoes CS 12 (3 minutes)
Detailed description
Patients who have agreed to participate in the study will complete the MRI protocol as part of routine care, to which a maximum of four additional 25-minute sequences will be added. MRI of routine care includes at least the following sequences: * 3D T1 TFE (2 minutes) * T2 TSE (2 minutes) * 3D FLAIR (3 minutes) The sequences added by the research lasting 25 minutes are: * SWI QSM 1.0iso 8 echoes (10 minutes) * SWI QSM 1.0iso 8 echoes CS 6 (7 minutes) * SWI QSM 1.0iso 8 echoes CS 9 (5 minutes) * SWI QSM 1.0iso 8 echoes CS 12 (3 minutes)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MRI | MRI of routine care includes at least the following sequences: * 3D T1 TFE (2 minutes) * T2 TSE (2 minutes) * 3D FLAIR (3 minutes) The sequences added by the research lasting 25 minutes are: * SWI QSM 1.0iso 8 echoes (10 minutes) * SWI QSM 1.0iso 8 echoes CS 6 (7 minutes) * SWI QSM 1.0iso 8 echoes CS 9 (5 minutes) * SWI QSM 1.0iso 8 echoes CS 12 (3 minutes) |
Timeline
- Start date
- 2021-12-15
- Primary completion
- 2025-05-14
- Completion
- 2025-05-14
- First posted
- 2021-05-28
- Last updated
- 2026-01-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04907487. Inclusion in this directory is not an endorsement.